Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Type 2 Diabetes”

4,904 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,904 results

Not applicableStudy completedNCT01091909
What this trial is testing

Post-extraction Wound Healing in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Sao Paulo 82
Not applicableStudy completedNCT03233178
What this trial is testing

Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)Fatty LiverNAFLD
LMC Diabetes & Endocrinology Ltd. 4,000
Not applicableNot Yet RecruitingNCT07124585
What this trial is testing

Short-Term Effects of Sucralose and Saccharin on Blood Sugar and Gut Microbiota in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
National University of Malaysia 33
Not applicableStudy completedNCT02405949
What this trial is testing

GENETIC SUSCEPTIBILITY FACTOR AS A PREDICTOR OF TYPE 2 DIABETES REMISSION AND WEIGHT LOSS AFTER BARIATRIC SURGERY

Who this might be right for
Case-control Study
Hospital Universitari Vall d'Hebron Research Institute 100
Not applicableEnded earlyNCT01303315
What this trial is testing

TANTALUS Therapy in Type 2 Diabetic Patients Intolerant or Inadequately Responsive to GLP-1 Receptor Agonist Therapy

Who this might be right for
Diabetes Mellitus, Type 2
MetaCure (USA), Inc. 20
Large-scale testing (Phase 3)Study completedNCT00044408
What this trial is testing

Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes

Who this might be right for
Diabetic NeuropathiesDiabetes Mellitus, Insulin-DependentDiabetes Mellitus, Non-Insulin-Dependent
Chromaderm, Inc. 200
Post-approval studies (Phase 4)Active Not RecruitingNCT05949008
What this trial is testing

Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo

Who this might be right for
NIDDMObesity
University of California, Los Angeles 150
Not applicableUnknownNCT04808804
What this trial is testing

Retinal Neurodegeneration In Type 2 Diabetes Mellitus Detected by Optical Coherence Tomography

Who this might be right for
Retinal NeuropathyNeurodegeneration
Assiut University 80
Not applicableLooking for participantsNCT07237685
What this trial is testing

Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus

Who this might be right for
Type 2 DiabetesCoronary Artery Disease (CAD)Atherosclerosis Cardiovascular Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,000
Not applicableLooking for participantsNCT06927271
What this trial is testing

Effectiveness of Phone Call and Video-based Interventions to Improve Adherence to Medications in Hypertensive Patients

Who this might be right for
HypertensionHypertension (Without Type 2 Diabetes Mellitus)
University of Ghana 1,400
Not applicableStudy completedNCT05336214
What this trial is testing

Implementing Continuous Glucose Monitoring in Primary Care for Patients With Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Continuous Glucose Monitoring
University of Colorado, Denver 190
Post-approval studies (Phase 4)Study completedNCT05002933
What this trial is testing

A Clinical Efficacy and Safety Study of Insulin Glargine U300 in Chinese Adult Patients With Uncontrolled Type 2 Diabetes Mellitus With a 3-month Extension Period

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 570
Not applicableStudy completedNCT03391349
What this trial is testing

Quantification of Proteomes: L-plastin , Lipocalin and Adiponectin in Chronic Periodontitis and Diabetic Subjects

Who this might be right for
Periodontal Diseases
Meenakshi Ammal Dental College and Hospital 70
Testing effectiveness (Phase 2)Ended earlyNCT02020616
What this trial is testing

The Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 60
Post-approval studies (Phase 4)Study completedNCT00902616
What this trial is testing

Effect of Arginine on Microcirculation in Patients With Diabetes

Who this might be right for
Type 2 Diabetes
Tameside Hospital NHS Foundation Trust 40
Not applicableUnknownNCT05924516
What this trial is testing

Randomized Clinical Trial to Evaluate the Efficacy of a Digital Intervention for Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Maria del Carmen Gogeascoechea Trejo 150
Post-approval studies (Phase 4)Study completedNCT01426802
What this trial is testing

Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Novartis Pharmaceuticals 150
Large-scale testing (Phase 3)Study completedNCT02622672
What this trial is testing

Water-soluble Ubiquinol Supplementation on Blood Glucose, Lipids, Oxidative Stress, and Inflammation in Diabetes

Who this might be right for
Diabetes
Yeh 50
Not applicableStudy completedNCT01359904
What this trial is testing

Effect of Dialysis Glucose Bath on Glycemic Control in Hemodialysis (HD)

Who this might be right for
Diabetes Type 2
McGill University Health Centre/Research Institute of the McGill University Health Centre 33
Large-scale testing (Phase 3)Study completedNCT02284893
What this trial is testing

Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

Who this might be right for
Type 2 Diabetes
AstraZeneca 461
Load More Results